EORTC 26081-22086
Phase III Intergroup Study of Radiotherapy versus Temozolomide Alone versus Radiotherapy with Concomitant and Adjuvant Temozolomide for Patients with Newly Diagnosed Anaplastic Oligodendroglioma or Anaplastic Mixed Glioma with Chromosomal Co-delections of 1p and 19q
Phase III Intergroup Study of Radiotherapy versus Temozolomide Alone versus Radiotherapy with Concomitant and Adjuvant Temozolomide for Patients with Newly Diagnosed Anaplastic Oligodendroglioma or Anaplastic Mixed Glioma with Chromosomal Co-delections of 1p and 19q
Protocol Participation Information
- How to Participate
- Digital Data Submission Information Form (for EORTC protocols)
- Data Items to Submit to ITC
- ATC Compliant Treatment Planning Systems
- QART Guidelines Document for EORTC 26081/NCCTG N0577 (July 2010)
- Protocol Text (23 Apr 2010)
Back to protocols
